Roundtable discussion on the latest advances in multiple myeloma therapy

Share :
Published: 2 Mar 2010
Views: 10101
Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig
Experts in haematology-oncology discuss the latest developments in multiple myeloma therapy, including highlights from ASH 2009. The discussion focuses on the evolving role of novel agents in the treatment of multiple myeloma, and how this translates to clinicians practice.

Supported by an unrestricted educational grant from Janssen-Cilag and HCA Cancer Care